Cisplatin
Top View
- Dbl Cisplatin Injection Data Sheet
- Systematic Review and Meta-Analysis of in Vitro Anti-Human Cancer Experiments Investigating the Use of 5-Aminolevulinic Acid (5-ALA) for Photodynamic Therapy
- Arsenic Trioxide Sensitivity Is Associated with Low Level Of
- 5-Aminolevulinic Acid Protects Against Cisplatin-Induced Nephrotoxicity Without Compromising the Anticancer Efficiency of Cisplatin in Rats in Vitro and in Vivo
- Inp- VTD-PACE (IV) Bortezomib
- The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy Via Transporter Regulation
- Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local Or Metastatic Esophageal Cancer
- Therapeutic Role of Arsenic Trioxide in Cancer Protection Archana Chaudhary and Rizwanul Haque*
- Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin As the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
- LUNG CANCER TREATMENT REGIMENS (Part 1 of 7) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- DRUG NAME: Cisplatin
- Association of High-Dose Cyclophosphamide, Cisplatin, And
- BC Cancer Protocol Summary for Adjuvant Therapy for Osteosarcoma Using Doxorubicin and Cisplatin
- Cisplatin Doxorubicin Sarcoma
- Protocol: Doxorubicin/Cisplatin Indications: Osteosarcoma
- Pdf 841.59 K